August 22, 2014 2:57 PM ET

Biotechnology

Company Overview of Protagonist Therapeutics, Inc.

Company Overview

Protagonist Therapeutics, Inc. operates as a biotechnology company that engages in the discovery and development of ‘orally stable peptides’ against validated targets and diseases that are being addressed by ‘injectable biologics’. The company focuses on developing oral peptides for inflammatory bowel diseases (IBD), irritable bowel syndrome, and other gastro-intestinal disorders. Its development portfolio includes a4ß7 integrin specific ‘oral peptide’ antagonist for the treatment of IBD; IL-6 peptide antagonist, which is used in the treatment of various diseases, such as IBD, psoriasis, and rheumatoid arthritis; Hepcidin, a natural peptide hormone that regulates iron homeostasis and its def...

521 Cottonwood Drive

Suite 100

Milpitas, CA 95035-7404

United States

Founded in 2001

Phone:

408-649-7370

Key Executives for Protagonist Therapeutics, Inc.

Chief Executive Officer
Founder and Vice President of Technology & Alliances
Director of Chemistry
Senior Director of Preclinical Development
Director of Biology
Compensation as of Fiscal Year 2014.

Protagonist Therapeutics, Inc. Key Developments

Protagonist Therapeutics, Inc. Presents at The 21st Annual Future Leaders in the Biotech Industry Conference, Mar-28-2014 03:00 PM

Protagonist Therapeutics, Inc. Presents at The 21st Annual Future Leaders in the Biotech Industry Conference, Mar-28-2014 03:00 PM. Venue: Millennium Broadway Hotel & Conference Center, New York, New York, United States.

Protagonist Therapeutics, Inc. Presents at 12th Annual BIO Investor Forum, Oct-08-2013 08:00 AM

Protagonist Therapeutics, Inc. Presents at 12th Annual BIO Investor Forum, Oct-08-2013 08:00 AM. Venue: The Palace Hotel, 2 New Montgomery Street, San Francisco, CA 94105, United States.

Protagonist Therapeutics, Inc. Appoints David Y. Liu, Ph.D. as Chief Scientific Officer

Protagonist Therapeutics, Inc. announced the appointment of David Y. Liu, Ph.D. as Chief Scientific Officer. Dr. Liu is a former Vice President of Research and a Corporate Officer at FibroGen Inc. with deep rooted knowledge and expertise in the fields of inflammation and fibrosis. David Y. Liu was most recently Chief Operating Officer and co-founder of Trenovus, Inc.

Similar Private Companies By Industry

Company Name Region
Cardio Technologies, Inc. United States
Antigenics, Inc. United States
Escape Therapeutics, Inc. United States
Celera Diagnostics, LLC United States
Clearside BioMedical, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Protagonist Therapeutics, Inc., please visit www.protagonist-inc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.